101
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The new way to synthesize ethyl 1-butyryloxy-1-phenylmethane(P-phenyl)phosphinate and whole-cell biocatalysis by Escherichia coli and Pseudomonas fluorescens

ORCID Icon
Pages 1048-1053 | Received 20 Nov 2018, Accepted 22 Mar 2019, Published online: 09 Apr 2019
 

Abstract

A new compound, ethyl 1-carboxy-1-hydroxy-1-phenylmethane(P-phenyl)phosphinate, was synthesized and the configuration of its diastereoisomers was described using NMR spectroscopy. Acylation with butyryl chloride gave an unexpected product, ethyl butyryloxy(phenyl)methane(P-phenyl)phosphinate, which was then hydrolyzed using two bacterial species as biocatalysts. Good results were achieved for biocatalytic hydrolysis performed by Escherichia coli cells, giving optically active products with 84% enantiomeric excess, and enantioselectivity of 25.8 for one pair of enantiomers. Better results were obtained when the biocatalytic reaction was carrying out for a longer period and the conversion degree reached 71%, the enantiomeric excess of unreacted substrate was >99% and enantioselectivity increased to 32.1. In all cases, isomers bearing α–carbon atom of S configuration were hydrolyzed preferentially.

Graphical Abstract

Acknowledgments

The author would like to thank student at the Department of Chemistry: E. Krawiec who helped in the implementation of the initial research on biotransformation reactions.

Disclosure statement

The author declare that there is no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.